Quadrant Capital Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Quadrant Capital Group's OGN Position: Q1 2026 in Review
Quadrant Capital Group reduced its Organon & Co (OGN) stake by 87% in Q1 2026, selling an estimated $7.95K and leaving 160 shares worth $959. The position accounts for ﹤0.01% of the portfolio, ranked #2591.
Quadrant Capital Group first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $803K in Q1 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Quadrant Capital Group held 160 shares of Organon & Co worth $959 as of Q1 2026.
- Quadrant Capital Group sold 1,057 Organon & Co shares in Q1 2026, an estimated $7.95K.
- Organon & Co made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2591 holding.
- Quadrant Capital Group first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
- Quadrant Capital Group's Organon & Co position peaked at $803K in Q1 2025.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.